BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1585772)

  • 21. The flow-cytometric DNA content of the plasma cells of patients with multiple myeloma is a prognostic factor: a single institution experience.
    López-Otero A; Ruiz-Delgado GJ; Hernández-Arizpe A; Ruiz-Argüelles A; Ruiz-Argüelles GJ
    Hematology; 2010 Dec; 15(6):378-81. PubMed ID: 21114899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A staging system for multiple myeloma based on the morphology of myeloma cells.
    Murakami H; Kawada T; Saitoh T; Uchiumi H; Moridaira K; Matsushima T; Tsukamoto N; Tamura J; Morita K; Sawamura M; Karasawa M; Miyawaki S; Shinonome S; Shimano S; Sato S; Ogawara H; Tsuchiya J
    Eur J Haematol; 1999 Jan; 62(1):63-7. PubMed ID: 9918314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple myeloma in serologic complete remission after autologous stem cell transplantation: impact of bone marrow plasma cell assessment by conventional morphology on disease progression.
    Fernández de Larrea C; Tovar N; Rozman M; Rosiñol L; Aróstegui JI; Cibeira MT; Rovira M; Yagüe J; Bladé J
    Biol Blood Marrow Transplant; 2011 Jul; 17(7):1084-7. PubMed ID: 21215814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating plasma cells in newly diagnosed symptomatic multiple myeloma as a possible prognostic marker for patients with standard-risk cytogenetics.
    Vagnoni D; Travaglini F; Pezzoni V; Ruggieri M; Bigazzi C; Dalsass A; Mestichelli F; Troiani E; Falcioni S; Mazzotta S; Natale A; Angelini M; Ferretti S; Angelini S; Galieni P
    Br J Haematol; 2015 Aug; 170(4):523-31. PubMed ID: 26010293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prognostic significance of CD45 expression by clonal bone marrow plasma cells in patients with newly diagnosed multiple myeloma.
    Gonsalves WI; Timm MM; Rajkumar SV; Morice WG; Dispenzieri A; Buadi FK; Lacy MQ; Dingli D; Leung N; Kapoor P; Kyle RA; Gertz MA; Kumar SK
    Leuk Res; 2016 May; 44():32-9. PubMed ID: 26994849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemical analysis of NOTCH1 and JAGGED1 expression in multiple myeloma and monoclonal gammopathy of undetermined significance.
    Skrtić A; Korać P; Krišto DR; Ajduković Stojisavljević R; Ivanković D; Dominis M
    Hum Pathol; 2010 Dec; 41(12):1702-10. PubMed ID: 20800871
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A magnetic resonance imaging-based prognostic scoring system to predict outcome in transplant-eligible patients with multiple myeloma.
    Mai EK; Hielscher T; Kloth JK; Merz M; Shah S; Raab MS; Hillengass M; Wagner B; Jauch A; Hose D; Weber MA; Delorme S; Goldschmidt H; Hillengass J
    Haematologica; 2015 Jun; 100(6):818-25. PubMed ID: 25795721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma cell maturity as a predictor of prognosis in multiple myeloma.
    Iriyama N; Miura K; Hatta Y; Uchino Y; Kurita D; Takahashi H; Sakagami H; Sakagami M; Kobayashi Y; Nakagawa M; Ohtake S; Iizuka Y; Takei M
    Med Oncol; 2016 Aug; 33(8):87. PubMed ID: 27383407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Appearance of monoclonal plasma cell diseases in whole-body magnetic resonance imaging and correlation with parameters of disease activity.
    Kloth JK; Hillengass J; Listl K; Kilk K; Hielscher T; Landgren O; Delorme S; Goldschmidt H; Kauczor HU; Weber MA
    Int J Cancer; 2014 Nov; 135(10):2380-6. PubMed ID: 24706394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The prognostic value of diagnosing concurrent multiple myeloma in immunoglobulin light chain amyloidosis.
    Dinner S; Witteles W; Witteles R; Lam A; Arai S; Lafayette R; George TI; Schrier SL; Liedtke M
    Br J Haematol; 2013 May; 161(3):367-72. PubMed ID: 23432783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical analysis of the prognostic value of ultrastructural abnormalities of plasma cells in patients with multiple myeloma.
    Kurabayashi H; Kubota K; Tamura J; Naruse T; Murakami H; Tsuchiya J
    Ultrastruct Pathol; 1998; 22(6):439-42. PubMed ID: 9891922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparative study of 2 prognostic classification systems for myeloma and examination of the correlation between initial bone marrow plasmacytosis and prognosis. A propos of a homogeneous population of 50 patients followed from diagnosis to death].
    Pesce A; Cassuto JP; Grisot C; Gratecos N; Bayle J; Viot G; Dujardin P
    Nouv Rev Fr Hematol (1978); 1983; 25(5):311-7. PubMed ID: 6657481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of apoptotic index in multiple myeloma patients treated by conventional therapy and novel agents, thalidomide and bortezomib.
    Minarik J; Scudla V; Ordeltova M; Bacovsky J; Pika T; Langova K
    Eur J Haematol; 2009 Dec; 83(6):528-34. PubMed ID: 19624720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Socioeconomic status and survival in multiple myeloma].
    Pasqualetti P; Colantonio D; Collacciani A; Casale R
    Minerva Med; 1990 Oct; 81(10):713-6. PubMed ID: 2234467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic significance of the serum phosphorus level and its relationship with other prognostic factors in multiple myeloma.
    Umeda M; Okuda S; Izumi H; Nagase D; Fujimoto Y; Sugasawa Y; Arai C; Natori K; Katoh M; Kuraishi Y
    Ann Hematol; 2006 Jul; 85(7):469-73. PubMed ID: 16528526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of plasma cell morphology in multiple myeloma.
    Paule B; Quillard J; Bisson M; Kahn MF; Massias P
    Nouv Rev Fr Hematol (1978); 1988; 30(4):209-12. PubMed ID: 3194186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Effect of Suppressed Levels of Uninvolved Immunoglobulins on the Prognosis of Symptomatic Multiple Myeloma.
    Sarı M; Sarı S; Nalçacı M
    Turk J Haematol; 2017 Jun; 34(2):131-136. PubMed ID: 27795224
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Proposal of a new staging system using scoring of multiple myeloma].
    Pasqualetti P; Collacciani A; Casale R; Colantonio D
    Medicina (Firenze); 1989; 9(4):410-3. PubMed ID: 2634228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased copy number of the interleukin-6 receptor gene is associated with adverse survival in multiple myeloma patients treated with autologous stem cell transplantation.
    Kim SY; Min HJ; Park HK; Oh B; Kim TY; She CJ; Hwang SM; Kim M; Kim HK; Kim I; Yoon SS; Park S; Kim BK; Lee JH; Lee DS;
    Biol Blood Marrow Transplant; 2011 Jun; 17(6):810-20. PubMed ID: 21220034
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic significance of morphological assessment of plasma cells in multiple myeloma.
    Al-Sahmani M; Trnavska I; Sevcikova S; Antosova M; Antosova L; Kissova J; Adam Z; Pour L; Nemec P; Greslikova H; Krejci M; Zahradova L; Bulikova A; Penka M; Hajek R
    Neoplasma; 2011; 58(6):554-60. PubMed ID: 21895410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.